Cetera Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.51M Buy
36,577
+20,439
+127% +$1.31M 0.02% 717
2023
Q4
$933K Buy
16,138
+135
+0.8% +$7.21K 0.01% 804
2023
Q3
$845K Buy
16,003
+645
+4% +$33.8K 0.01% 793
2023
Q2
$831K Buy
15,358
+958
+7% +$50K 0.01% 798
2023
Q1
$720K Buy
14,400
+3,408
+31% +$161K 0.01% 830
2022
Q4
$509K Buy
10,992
+1,163
+12% +$50.4K 0.01% 968
2022
Q3
$381K Buy
9,829
+195
+2% +$7.82K 0.01% 891
2022
Q2
$359K Sell
9,634
-804
-8% -$32.7K 0.01% 977
2022
Q1
$462K Sell
10,438
-1,189
-10% -$51.5K 0.01% 921
2021
Q4
$494K Sell
11,627
-2,215
-16% -$93.1K 0.01% 890
2021
Q3
$601K Buy
13,842
+3,175
+30% +$140K 0.01% 807
2021
Q2
$456K Buy
10,667
+959
+10% +$40.3K 0.01% 859
2021
Q1
$375K Buy
9,708
+205
+2% +$7.76K 0.01% 858
2020
Q4
$342K Buy
9,503
+47
+0.5% +$1.69K 0.01% 777
2020
Q3
$361K Buy
9,456
+435
+5% +$16.8K 0.01% 670
2020
Q2
$317K Sell
9,021
-107
-1% -$3.85K 0.01% 686
2020
Q1
$298K Sell
9,128
-5,539
-38% -$216K 0.02% 598
2019
Q4
$661K Buy
14,667
+1,259
+9% +$52.7K 0.03% 466
2019
Q3
$543K Sell
13,408
-403
-3% -$17.1K 0.02% 514
2019
Q2
$592K Sell
13,811
-4,492
-25% -$173K 0.03% 513
2019
Q1
$701K Buy
18,303
+8,649
+90% +$330K 0.03% 409
2018
Q4
$340K Sell
9,654
-3,048
-24% -$111K 0.02% 596
2018
Q3
$491K Sell
12,702
-1,083
-8% -$37.8K 0.02% 571
2018
Q2
$452K Buy
+13,785
New +$416K 0.03% 531
2016
Q3
Sell
-16,457
Closed -$386K 777
2016
Q2
$386K Buy
16,457
+87
+0.5% +$1.88K 0.03% 495
2016
Q1
$309K Buy
16,370
+200
+1% +$3.51K 0.03% 515
2015
Q4
$298K Hold
16,170
0.03% 540
2015
Q3
$265K Sell
16,170
-1,910
-11% -$32.6K 0.03% 526
2015
Q2
$321K Hold
18,080
0.03% 496
2015
Q1
$321K Hold
18,080
0.03% 482
2014
Q4
$241K Sell
18,080
-800
-4% -$10.2K 0.02% 544
2014
Q3
$222K Sell
18,880
-375
-2% -$4.72K 0.02% 522
2014
Q2
$247K Buy
+19,255
New +$250K 0.03% 484

Other funds holding BSX